Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a common, multisystemic, and progressive hereditary disease. It accounts for 6 to 8% of incident cases of end-stage chronic renal disease (ESRD) in developed countries. The aim of this study is to describe the predictive factors for the development of end-stage chronic kidney disease (CKD) in the course of this disease. M aterial and Methods : This is a retrospective, descriptive, and analytical study including 300 cases of ADPKD collected at the Nephrology Department of Ibn-Sina Hospital in Rabat over a period of 30 years (1993 to 2023). Included in the study are all patients with ADPKD meeting the ultrasound diagnostic criteria. The analysis focused on demographic, clinical, paraclinical, evolutionary data, as well as prognostic factors associated with renal function deterioration. Results: The mean age of patients at diagnosis is 51.53 +/− 17 years [16 - 93] with a male predominance. The median serum creatinine at diagnosis is 15.5 mg/l [10 - 34]. 21% of patients had ESRD (eGFR 300 mg/24h (21%). The most common cystic complication is hemorrhage (12.3%). 21.3% of patients had hepatorenal polycystic disease. In adjusted analysis, the predictive risk factors for the occurrence of ESRD were smoking (p = 0.019), anemia (p Conclusion: ADPKD can progress insidiously to ESRD. Identification and early treatment of predictive factors for poor renal prognosis could contribute to a better outcome for this disease.
KeywordsADPKDESRDFactors of Poor Renal PrognosisRenal and Extra-Renal Manifestations
Reule, S., Sexton, D.J., Solid, C.A., Chen, S., Collins, A.J. and Foley, R.N. (2014) ESRD from Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010. American Journal of Kidney Diseases , 64, 592-599. https://doi.org/10.1053/j.ajkd.2014.05.020
Melander, C., Joly, D. and Knebelmann, B. (2010) Polykystose rénale autosomique dominante: La lumière au bout du tunnel? Néphrologie & Thérapeutique , 6, 226-231. https://doi.org/10.1016/j.nephro.2010.02.004
Dachy, A., Collard, L., Krzesinski, J.M., et al. (2020) Polykystose Rénale Autosomique Dominante. Revue Médicale de Liège , 75, 775-780.
Grantham, J.J., Chapman, A.B. and Torres, V.E. (2006) Volume Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American S o ciety of Nephrology , 1, 148-157. https://doi.org/10.2215/cjn.00330705
Nowak, K.L., Cadnapaphornchai, M.A., Chonchol, M.B., Schrier, R.W. and Gitomer, B. (2016) Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology , 44, 171-178. https://doi.org/10.1159/000448695
Harris, P.C., Bae, K.T., Rossetti, S., Torres, V.E., Grantham, J.J., Chapman, A.B., et al. (2006) Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology , 17, 3013-3019. https://doi.org/10.1681/asn.2006080835
Grantham, J.J., Torres, V.E., Chapman, A.B., Guay-Woodford, L.M., Bae, K.T., King, B.F., et al. (2006) Volume Progression in Polycystic Kidney Disease. New England Journal of Medicine , 354, 2122-2130. https://doi.org/10.1056/nejmoa054341
Meijer, E., Rook, M., Tent, H., Navis, G., van der Jagt, E.J., de Jong, P.E., et al. (2010) Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology , 5, 1091-1098. https://doi.org/10.2215/cjn.00360110
Noël, N. and Rieu, P. (2015) Pathophysiologie, épidémiologie, présentation clinique, diagnostic et options thérapeutiques dans la polykystose rénale autosomique dominante. Néphrologie & Thérapeutique , 11, 213-225. https://doi.org/10.1016/j.nephro.2015.04.001
Ristovska, V., Kuzmanovska, S.P., Stojanoska, A., et al. (2020) Influence of Nephrolithiasis and Urinary Tract Infections on the Renal Function in Autosomal Dominant Polycystic Kidney Disease. BANTAO Journal , 18, 14.
Livio, F., Biollaz, J. and Burnier, M. (2008) Estimation de la fonction rénale par l’équation MDRD : intérêt et limites pour l’adaptation des doses de médicaments. Revue Médicale Suisse , 4, 2596-2600. https://doi.org/10.53738/revmed.2008.4.181.2596
Torres, V.E. and Harris, P.C. (2009) Autosomal Dominant Polycystic Kidney Disease: The Last 3 Years. Kidney International , 76, 149-168. https://doi.org/10.1038/ki.2009.128
Park, H., Paek, J.H., Kim, Y., Park, W.Y., Han, S. and Jin, K. (2022) Clinical Characteristics and Risk Factors for Kidney Failure in Patients with Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study. Medicine , 101, e31838. https://doi.org/10.1097/md.0000000000031838
Hajji, M., Barbouch, S., Harzallah, A., Hedri, H., Kaaroud, H., Abderrahim, E., et al. (2019) Clinical Study on Autosomal Dominant Polycystic Kidney Disease among North Tunisians. Saudi Journal of Kidney Diseases and Transplantation , 30, 175-184. https://doi.org/10.4103/1319-2442.252908
Kane, Y., Cissé, M. M., & Wone, I. (2019) Polykystose rénale autosomique domi-nante: Expérience de trois centres semi-urbains du sénégal. Health Sciences and Diseases , 20, 100.
Alam, A. (2015) Risk Factors for Progression in ADPKD. Current Opinion in Nephrology and Hypertension , 24, 290-294. https://doi.org/10.1097/mnh.0000000000000113
Taylor, M., Johnson, A.M., Tison, M., Fain, P. and Schrier, R.W. (2005) Earlier Diagnosis of Autosomal Dominant Polycystic Kidney Disease: Importance of Family History and Implications for Cardiovascular and Renal Complications. American Journal of Kidney Diseases , 46, 415-423. https://doi.org/10.1053/j.ajkd.2005.05.029
Scolari, F., Dallera, N., Saletti, A., Terlizzi, V. and Izzi, C. (2016) ADPKD: Fattori di progressione della Malattia Renale [ADPKD: Predictors of Renal Disease Progression]. Giornale Italiano di Nefrologia , 33.
Malakoutian, T., Izadi, S., Honarpisheh, P., Bagheri, S.M., Saffarzadeh, N. and Akbari, H. (2023) Estimating Patient Survival and Risk of End-Stage Kidney Disease in Patients with Autosomal Dominant Polycystic Kidney Disease in Iran. Iranian Journal of Kidney Diseases , 17, 141-149.
(2012) Progresión de la enfermedad renal crónica en pacientes con enfermedad poliquística autosómica dominante. Nefrología , 32, 199.
Schrier, R.W., Brosnahan, G., Cadnapaphornchai, M.A., Chonchol, M., Friend, K., Gitomer, B., et al. (2014) Predictors of Autosomal Dominant Polycystic Kidney Disease Progression. Journal of the American Society of Nephrology , 25, 2399-2418. https://doi.org/10.1681/asn.2013111184
Gabow, P.A., Johnson, A.M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T., et al. (1992) Factors Affecting the Progression of Renal Disease in Autosomal-Dominant Polycystic Kidney Disease. Kidney International , 41, 1311-1319. https://doi.org/10.1038/ki.1992.195
Kelleher, C., Mcfann, K., Johnson, A. and Schrier, R. (2004) Characteristics of Hypertension in Young Adults with Autosomal Dominant Polycystic Kidney Disease Compared with the General U.S. Population. American Journal of Hyperte n sion , 17, 1029-1034. https://doi.org/10.1016/j.amjhyper.2004.06.020
Geberth, E.R.S., Zeier, M., Gebert, S. and Waldherr, R. (1993) Autosomal Dominant Polycystic Kidney Disease (ADPKD)—Mechanisms of Cyst Formation and Renal Failure. Australian and New Zealand Journal of Medicine , 23, 35-41. https://doi.org/10.1111/j.1445-5994.1993.tb00535.x
Ka, E.F., Seck, S.M., Niang, A., Cisse, M.M. and Diouf, B. (2010) Patterns of Autosomal Dominant Polycystic Kidney Diseases in Black Africans. Saudi Journal of Kidney Diseases and Transplantation , 21, 81-86.
Orskov, B., Rømming Sørensen, V., Feldt-Rasmussen, B. and Strandgaard, S. (2010) Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark. Clinical Journal of the American Society of Nephrology , 5, 2034-2039. https://doi.org/10.2215/cjn.01460210
Orth, S.R., Stöckmann, A., Conradt, C., Ritz, E., Ferro, M., Kreusser, W., et al. (1998) Smoking as a Risk Factor for End-Stage Renal Failure in Men with Primary Renal Disease. Kidney International , 54, 926-931. https://doi.org/10.1046/j.1523-1755.1998.00067.x
Hateboer, N., Dijk, M.A., Bogdanova, N., Coto, E., Saggar-Malik, A.K., Millan, J.L.S., et al. (1999) Comparison of Phenotypes of Polycystic Kidney Disease Types 1 and 2. The Lancet , 353, 103-107. https://doi.org/10.1016/s0140-6736(98)03495-3
Dicks, E., Ravani, P., Langman, D., Davidson, W.S., Pei, Y. and Parfrey, P.S. (2006) Incident Renal Events and Risk Factors in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology , 1, 710-717. https://doi.org/10.2215/cjn.01581105
Idrizi, A., Barbullushi, M., Strakosha, A., Kodra, S., Thereska, N., Zaimi, E., et al. (2007) [The Relation of Hypertension, Renal Function and Cardiovascular Events in Autosomal Dominant Polycystic Kidney Disease]. Giornale Italiano di Nefrologia , 24, 595-599.
Choukroun, G., Itakura, Y., Albouze, G., Christophe, J.L., Man, N.K., Grünfeld, J.P., et al. (1995) Factors Influencing Progression of Renal Failure in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology , 6, 1634-1642. https://doi.org/10.1681/asn.v661634
Ahmed, E.R., Tashkandi, M.A., Nahrir, S. and Maulana, A. (2006) Retrospective Analysis of Factors Affecting the Progression of Chronic Renal Failure in Adult Polycystic Kidney disease. Saudi Journal of Kidney Diseases and Transplantation , 17, 511-515.
Patch, C., Charlton, J., Roderick, P.J. and Gulliford, M.C. (2011) Use of Antihypertensive Medications and Mortality of Patients with Autosomal Dominant Polycystic Kidney Disease: A Population-Based Study. American Journal of Kidney Diseases , 57, 856-862. https://doi.org/10.1053/j.ajkd.2011.01.023
Ozkok, A., Akpinar, T.S., Tufan, F., Kanitez, N.A., Uysal, M., Guzel, M., et al. (2012) Clinical Characteristics and Predictors of Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease: A Single Center Experience. Cli n ical and Experimental Nephrology , 17, 345-351. https://doi.org/10.1007/s10157-012-0706-3
Eckardt, K.U., Möllmann, M., Neumann, R., Brunkhorst, R., Burger, H.U., Lonnemann, G., et al. (1989) Erythropoietin in Polycystic Kidneys. Journal of Clinical I n vestigation , 84, 1160-1166. https://doi.org/10.1172/jci114280
de Almeida, E.A.F., Alho, I., Marques, F., Thiran, C., Bicho, M.P. and Prata, M. (2007) Haemoglobin and Erythropoietin Levels in Polycystic Kidney Disease. Nephrology Dialysis Transplantation , 23, 412-413. https://doi.org/10.1093/ndt/gfm717
Chandra, M., Miller, M.E., Garcia, J.F., Mossey, R.T. and McVicar, M. (1985) Serum Immunoreactive Erythropoietin Levels in Patients with Polycystic Kidney Disease as Compared with Other Hemodialysis Patients. Nephron , 39, 26-29. https://doi.org/10.1159/000183332
Ushio, Y., Kataoka, H., Sato, M., Manabe, S., Watanabe, S., Akihisa, T., et al. (2020) Association between Anemia and Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study. Clinical and Experimental Nephrol o gy , 24, 500-508. https://doi.org/10.1007/s10157-020-01856-1
Klahr, S., Breyer, J.A., Beck, G.J., Dennis, V.W., Hartman, J.A., Roth, D., et al. (1995) Dietary Protein Restriction, Blood Pressure Control, and the Progression of Polycystic Kidney Disease. Modification of Diet in Renal Disease Study Group. Journal of the American Society of Nephrology , 5, 2037-2047. https://doi.org/10.1681/asn.v5122037
Chapman, A.B., Johnson, A.M., Gabow, P.A. and Schrier, R.W. (1994) Overt Proteinuria and Microalbuminuria in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology , 5, 1349-1354. https://doi.org/10.1681/asn.v561349
Idrizi, A., Barbullushi, M., Petrela, E., Kodra, S., Koroshi, A. and Thereska, N. (2009) The Influence of Renal Manifestations to the Progression of Autosomal Dominant Polycystic Kidney Disease. Hippokratia , 13, 161-164.
Johnson, A.M. and Gabow, P.A. (1997) Identification of Patients with Autosomal Dominant Polycystic Kidney Disease at Highest Risk for End-Stage Renal Disease. Journal of the American Society of Nephrology , 8, 1560-1567. https://doi.org/10.1681/asn.v8101560
Milutinovic, J., Fialkow, P.J., Agodoa, L.Y., Phillips, L.A., Rudd, T.G. and Bryant, J.I. (1984) Autosomal Dominant Polycystic Kidney Disease: Symptoms and Clinical Findings. QJM : An International Journal of Medicine , 53, 511-522.
Dalgaard, O.A. (1971) Polycystic Disease of the Kidneys. Diseases of the Kidney , 1223-1258.
Hogan, M.C., Abebe, K., Torres, V.E., Chapman, A.B., Bae, K.T., Tao, C., et al. (2015) Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease. Clinical Gastroenterology and Hepatology , 13, 155-164.e6. https://doi.org/10.1016/j.cgh.2014.07.051
Bae, K.T., Zhu, F., Chapman, A.B., Torres, V.E., Grantham, J.J., Guay-Woodford, L.M., et al. (2006) Magnetic Resonance Imaging Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology , 1, 64-69. https://doi.org/10.2215/cjn.00080605
Hoevenaren, I.A., Wester, R., Schrier, R.W., McFann, K., Doctor, R.B., Drenth, J.P.H., et al. (2007) Polycystic Liver: Clinical Characteristics of Patients with Isolated Polycystic Liver Disease Compared with Patients with Polycystic Liver and Autosomal Dominant Polycystic Kidney Disease. Liver International , 28, 264-270. https://doi.org/10.1111/j.1478-3231.2007.01595.x
Kim, Y., Park, H.C., Ryu, H., Kim, Y.C., Ahn, C., Lee, K., et al. (2023) Factors Associated with the Development and Severity of Polycystic Liver in Patients with Autosomal Dominant Polycystic Kidney Disease. Journal of Korean Medical Science , 38, e296. https://doi.org/10.3346/jkms.2023.38.e296